FDA Approved: ZOLEDRONIC ACID — Supplemental Application (BPI Labs LLC)

View source ↗

Summary

FDA approves a supplemental application for zoledronic acid from BPI Labs LLC under ANDA 202930. This action supports continued availability of the generic prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Breast Cancer with Bone Metastases
• Hypercalcemia of Malignancy
• Multiple Myeloma
• Osteoporosis
• Paget Disease of Bone

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

SUPPL AP for ZOLEDRONIC ACID (ZOLEDRONIC ACID)